Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Immunotherapy of Cancer

Immunotherapy of Cancer

Aus der Reihe Cancer Drug Discovery and Development

Fr. 242.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

15.12.2005

Abbildungen

52 schwarzweisse Abbildungen, 6 Abbildungenton-Abb., 46 schwarzweisse Zeichnungen 254 mm

Herausgeber

Mary L. Disis

Verlag

Humana Press

Seitenzahl

516

Maße (L/B/H)

26.1/18.2/3.8 cm

Gewicht

1112 g

Auflage

2006 edition

Sprache

Englisch

ISBN

978-1-58829-564-4

Beschreibung

Rezension

From the reviews:



"Immunotherapy of Cancer provides in 28 chapters a comprehensive overview of experimental and clinical achievements in tumor immunology. Each chapter is designed to give the reader the scientific basis behind the discussed therapy and outline basic theory, as well as practical treatment applications. … The book belongs to the successful series of publications Cancer Drug Discovery and Development from Humana Press. It will be of interest to clinicians and to laboratory cancer researchers … ." (Cestmir Altaner, Neoplasma, Vol. 54 (2), March, 2007)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

15.12.2005

Abbildungen

52 schwarzweisse Abbildungen, 6 Abbildungenton-Abb., 46 schwarzweisse Zeichnungen 254 mm

Herausgeber

Mary L. Disis

Verlag

Humana Press

Seitenzahl

516

Maße (L/B/H)

26.1/18.2/3.8 cm

Gewicht

1112 g

Auflage

2006 edition

Sprache

Englisch

ISBN

978-1-58829-564-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Immunotherapy of Cancer
  • Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches
    Özlem Türeci, Thorsten Klamp, Michael Koslowski, Sebastian Kreiter, and Ugur Sahin

    Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens
    Ludmila Müller, Stephanie McArdle, Evelyna Derhovanessian, Thomas Flad, Ashley Knights, Robert Rees, and Graham Pawelec

    Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy
    Lisa M. Harlan and Julie Y. Djeu

    The Role of Immune Monitoring in Evaluating Cancer Immunotherapy
    Holden T. Maecker

    Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials
    Susan Groshen

    DNA Vaccines for Cancer Immunotherapy
    Heesun Kwak and Howard L. Kaufman

    Dendritic Cells
    Weiping Zou and Tyler J. Curiel

    Different Approaches to Dendritic Cell-Based Cancer Immunotherapy
    Noweeda Mirza and Dmitry Gabrilovich

    Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer
    Malaya Bhattacharya-Chatterjee, Nitin Rohatgi, Sunil K. Chatterjee, Asim Saha, Rakesh Shukla, and Kenneth A. Foon

    Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics
    Jie Dai and Zihai Li

    Tumor-Reactive T-Cells for Adoptive Immunotherapy
    Helga Bernhard, Julia Neudorfer, Kerstin Gebhard, Heinke Conrad, Dirk H. Busch, and Christian Peschel

    T-Cell Adoptive Immunotherapy of Cancer: From Translational Models to Clinical Significance
    Peter A. Cohen, Mohamed Awad, and Suyu Shu

    Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells
    Jeffrey J. Roszkowski and Michael I. Nishimura

    Harnessing the Potential of Graft-vs-Tumor
    Nancy M. Hardy and Michael R. Bishop

    Tumor-Induced Immune Suppression and Immune Escape: Mechanisms and Impact on the Outcome ofImmunotherapy of Malignant Disease
    Michael Campoli and Soldano Ferrone

    The Tumor Microenvironment: Regulation of Antitumor Immunity and Implications for Immunotherapy
    George Coukos and Jose-Ramon Conejo-Garcia

    Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity
    Eduardo Davila and Esteban Celis

    Fast-Lane Evolution in the Tumor Microenvironment
    Gabriella Marincola and Francesco M. Marincola

    Manipulating Immunological Checkpoints to Maximize Antitumor Immunity
    Leisha A. Emens, R. Todd Reilly, and Elizabeth M. Jaffee

    Interleukin-2 as Cancer Therapy
    Joseph I. Clark and Kim A. Margolin

    Biological and Clinical Properties of the Type 1 Interferons
    Douglas W. Leaman, Shaun Rosebeck, and Ernest C. Borden

    Promising g-Chain Cytokines for Cancer Immunotherapy: Interleukins-7, -15, and -21 as Vaccine Adjuvants, Growth Factors and Immunorestoratives
    Terry J. Fry and Crystal L. Mackall

    The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies
    Sherif S. Farag and Michael A. Caligiuri

    Antibody Therapy for Solid Tumors
    Cristina I. Truica, Dorinda Rouch, and Carlos L. Arteaga

    Antibody Therapy for Non-Hodgkin's Lymphoma
    Stephen M. Ansell and Thomas E. Witzig

    Approaches to In Vivo Imaging of Cancer Immunotherapy
    George A. Vielhauer, Bond Almand, Mary L. Disis, David A. Mankoff, and Keith L. Knutson

    Design Issues for Early-Stage Clinical Trials for Cancer Vaccines
    Gina R. Petroni

    Monoclonal Antibody Therapy of Cancer
    Hossein Borghaei, Matthew K. Robinson, and Louis M. Weiner

    Index